
Ikena Oncology (NASDAQ:IKNA) brought in sales totaling $3.38 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 702.04%, resulting in a loss of $16.84 million. Ikena Oncology reached earnings of $2.80 million and sales of $20.22 million in Q4.